| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4453626
Max Phase: Preclinical
Molecular Formula: C20H19FN6O2
Molecular Weight: 394.41
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: O=C(NCc1ncccc1F)c1cnc(CCNCc2nc3ccccc3[nH]2)o1
Standard InChI: InChI=1S/C20H19FN6O2/c21-13-4-3-8-23-16(13)10-25-20(28)17-11-24-19(29-17)7-9-22-12-18-26-14-5-1-2-6-15(14)27-18/h1-6,8,11,22H,7,9-10,12H2,(H,25,28)(H,26,27)
Standard InChI Key: LQZZWBRMBZQXRE-UHFFFAOYSA-N
Associated Targets(Human)
SLC40A1 Tchem Solute carrier family 40 member 1 (725 Activities)
Associated Targets(non-human)
Slc40a1 Solute carrier family 40 member 1 (216 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 394.41 | Molecular Weight (Monoisotopic): 394.1554 | AlogP: 2.35 | #Rotatable Bonds: 8 |
| Polar Surface Area: 108.73 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.23 | CX Basic pKa: 7.86 | CX LogP: 0.59 | CX LogD: 0.01 |
| Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.40 | Np Likeness Score: -1.78 |
References
| 1. (2018) Novel Ferroportin Inhibitors, |
Source
Source(1):